229 related articles for article (PubMed ID: 25720553)
1. Circulating Biomarker Panels in Alzheimer's Disease.
Zafari S; Backes C; Meese E; Keller A
Gerontology; 2015; 61(6):497-503. PubMed ID: 25720553
[TBL] [Abstract][Full Text] [Related]
2. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
[TBL] [Abstract][Full Text] [Related]
3. Peripheral biomarkers of Alzheimer's disease.
Khan TK; Alkon DL
J Alzheimers Dis; 2015; 44(3):729-44. PubMed ID: 25374110
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.
Galozzi S; Marcus K; Barkovits K
Expert Rev Proteomics; 2015 Aug; 12(4):343-54. PubMed ID: 26153725
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
6. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H
J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677
[TBL] [Abstract][Full Text] [Related]
7. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
Robinson RA; Amin B; Guest PC
Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
[TBL] [Abstract][Full Text] [Related]
8. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
9. Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
Lista S; Zetterberg H; O'Bryant SE; Blennow K; Hampel H
Methods Mol Biol; 2017; 1598():101-115. PubMed ID: 28508359
[TBL] [Abstract][Full Text] [Related]
10. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
[TBL] [Abstract][Full Text] [Related]
11. The development of effective biomarkers for Alzheimer's disease: a review.
Henry MS; Passmore AP; Todd S; McGuinness B; Craig D; Johnston JA
Int J Geriatr Psychiatry; 2013 Apr; 28(4):331-40. PubMed ID: 22674539
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
13. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
Engelborghs S
Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
15. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in Sporadic and Familial Alzheimer's Disease.
Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for preclinical Alzheimer's disease.
Tan CC; Yu JT; Tan L
J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease biomarkers: correspondence between human studies and animal models.
Sabbagh JJ; Kinney JW; Cummings JL
Neurobiol Dis; 2013 Aug; 56():116-30. PubMed ID: 23631871
[TBL] [Abstract][Full Text] [Related]
19. Beyond statistics: a new combinatorial approach to identifying biomarker panels for the early detection and diagnosis of Alzheimer's disease.
Milward EA; Moscato P; Riveros C; Johnstone DM
J Alzheimers Dis; 2014; 39(1):211-7. PubMed ID: 24145380
[TBL] [Abstract][Full Text] [Related]
20. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
